Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects

Clinical trial NCT00498914 · TERMINATED

Trial details

NCT number: NCT00498914
Sponsor: Astellas Pharma Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Large-Cell, Diffuse Lymphoma, B-Cell Refractory

Start date: 2007-06-01
Primary completion: 2009-04-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.